ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $8,067,000 | -2.1% | 199,587 | +39.3% | 0.01% | +14.3% |
| Q2 2015 | $8,243,000 | -2.3% | 143,245 | +8.1% | 0.01% | -22.2% |
| Q1 2015 | $8,438,000 | +37.9% | 132,504 | +33.7% | 0.01% | +80.0% |
| Q4 2014 | $6,120,000 | +203.4% | 99,114 | +90.8% | 0.01% | +150.0% |
| Q3 2014 | $2,017,000 | +35.4% | 51,949 | +20.1% | 0.00% | +100.0% |
| Q2 2014 | $1,490,000 | -46.0% | 43,272 | -32.3% | 0.00% | -66.7% |
| Q1 2014 | $2,761,000 | -5.4% | 63,896 | -12.8% | 0.00% | 0.0% |
| Q4 2013 | $2,918,000 | +74.2% | 73,237 | +64.1% | 0.00% | +50.0% |
| Q3 2013 | $1,675,000 | +62.6% | 44,621 | +16.4% | 0.00% | +100.0% |
| Q2 2013 | $1,030,000 | – | 38,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |